Style | Citing Format |
---|---|
MLA | Abedini A, et al.. "Dose Assessment in Radiotherapy of Head and Neck Cancer After Metal Artifact Reduction in Neusoft-Philips Corporation Ct Scanner: A Clinical Study." Frontiers in Biomedical Technologies, vol. 10, no. 1, 2023, pp. -. |
APA | Abedini A, Gorji KE, Ghaemian N, Varaki SS, Davoudi M, Agbele AT, Monfared AS (2023). Dose Assessment in Radiotherapy of Head and Neck Cancer After Metal Artifact Reduction in Neusoft-Philips Corporation Ct Scanner: A Clinical Study. Frontiers in Biomedical Technologies, 10(1), -. |
Chicago | Abedini A, Gorji KE, Ghaemian N, Varaki SS, Davoudi M, Agbele AT, Monfared AS. "Dose Assessment in Radiotherapy of Head and Neck Cancer After Metal Artifact Reduction in Neusoft-Philips Corporation Ct Scanner: A Clinical Study." Frontiers in Biomedical Technologies 10, no. 1 (2023): -. |
Harvard | Abedini A et al. (2023) 'Dose Assessment in Radiotherapy of Head and Neck Cancer After Metal Artifact Reduction in Neusoft-Philips Corporation Ct Scanner: A Clinical Study', Frontiers in Biomedical Technologies, 10(1), pp. -. |
Vancouver | Abedini A, Gorji KE, Ghaemian N, Varaki SS, Davoudi M, Agbele AT, et al.. Dose Assessment in Radiotherapy of Head and Neck Cancer After Metal Artifact Reduction in Neusoft-Philips Corporation Ct Scanner: A Clinical Study. Frontiers in Biomedical Technologies. 2023;10(1):-. |
BibTex | @article{ author = {Abedini A and Gorji KE and Ghaemian N and Varaki SS and Davoudi M and Agbele AT and Monfared AS}, title = {Dose Assessment in Radiotherapy of Head and Neck Cancer After Metal Artifact Reduction in Neusoft-Philips Corporation Ct Scanner: A Clinical Study}, journal = {Frontiers in Biomedical Technologies}, volume = {10}, number = {1}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Abedini A AU - Gorji KE AU - Ghaemian N AU - Varaki SS AU - Davoudi M AU - Agbele AT AU - Monfared AS TI - Dose Assessment in Radiotherapy of Head and Neck Cancer After Metal Artifact Reduction in Neusoft-Philips Corporation Ct Scanner: A Clinical Study JO - Frontiers in Biomedical Technologies VL - 10 IS - 1 SP - EP - PY - 2023 ER - |